Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2).

Trial Profile

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2).

Suspended
Phase of Trial: Phase I

Latest Information Update: 10 May 2012

At a glance

  • Drugs Astressin; Substance P; Urocortin 2; Urocortin 3
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 May 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
    • 14 Feb 2011 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
    • 14 Feb 2011 Planned end date changed from 1 Feb 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top